233 related articles for article (PubMed ID: 11574470)
1. Proteasomes and ubiquitin are involved in the turnover of the wild-type prion protein.
Yedidia Y; Horonchik L; Tzaban S; Yanai A; Taraboulos A
EMBO J; 2001 Oct; 20(19):5383-91. PubMed ID: 11574470
[TBL] [Abstract][Full Text] [Related]
2. Prion protein is ubiquitinated after developing protease resistance in the brains of scrapie-infected mice.
Kang SC; Brown DR; Whiteman M; Li R; Pan T; Perry G; Wisniewski T; Sy MS; Wong BS
J Pathol; 2004 May; 203(1):603-8. PubMed ID: 15095484
[TBL] [Abstract][Full Text] [Related]
3. Ubiquitin-proteasome pathway mediates intracellular degradation of apolipoprotein B.
Yeung SJ; Chen SH; Chan L
Biochemistry; 1996 Oct; 35(43):13843-8. PubMed ID: 8901527
[TBL] [Abstract][Full Text] [Related]
4. Effects of tocotrienol on the intracellular translocation and degradation of apolipoprotein B: possible involvement of a proteasome independent pathway.
Wang Q; Theriault A; Gapor A; Adeli K
Biochem Biophys Res Commun; 1998 May; 246(3):640-3. PubMed ID: 9618265
[TBL] [Abstract][Full Text] [Related]
5. Two endoplasmic reticulum-associated degradation (ERAD) systems for the novel variant of the mutant dysferlin: ubiquitin/proteasome ERAD(I) and autophagy/lysosome ERAD(II).
Fujita E; Kouroku Y; Isoai A; Kumagai H; Misutani A; Matsuda C; Hayashi YK; Momoi T
Hum Mol Genet; 2007 Mar; 16(6):618-29. PubMed ID: 17331981
[TBL] [Abstract][Full Text] [Related]
6. Scrapie-like prion protein accumulates in aggresomes of cyclosporin A-treated cells.
Cohen E; Taraboulos A
EMBO J; 2003 Feb; 22(3):404-17. PubMed ID: 12554642
[TBL] [Abstract][Full Text] [Related]
7. Processing of N-linked glycans during endoplasmic-reticulum-associated degradation of a short-lived variant of ribophorin I.
Kitzmüller C; Caprini A; Moore SE; Frénoy JP; Schwaiger E; Kellermann O; Ivessa NE; Ermonval M
Biochem J; 2003 Dec; 376(Pt 3):687-96. PubMed ID: 12952521
[TBL] [Abstract][Full Text] [Related]
8. Cellular tolerance of prion protein PrP in yeast involves proteolysis and the unfolded protein response.
Apodaca J; Kim I; Rao H
Biochem Biophys Res Commun; 2006 Aug; 347(1):319-26. PubMed ID: 16808901
[TBL] [Abstract][Full Text] [Related]
9. Chaperone interactions of the metalloproteinase meprin A in the secretory or proteasomal-degradative pathway.
Tsukuba T; Kadowaki T; Hengst JA; Bond JS
Arch Biochem Biophys; 2002 Jan; 397(2):191-8. PubMed ID: 11795871
[TBL] [Abstract][Full Text] [Related]
10. Mutant PrP is delayed in its exit from the endoplasmic reticulum, but neither wild-type nor mutant PrP undergoes retrotranslocation prior to proteasomal degradation.
Drisaldi B; Stewart RS; Adles C; Stewart LR; Quaglio E; Biasini E; Fioriti L; Chiesa R; Harris DA
J Biol Chem; 2003 Jun; 278(24):21732-43. PubMed ID: 12663673
[TBL] [Abstract][Full Text] [Related]
11. Ubiquitin-dependent and -independent proteasomal degradation of apoB associated with endoplasmic reticulum and Golgi apparatus, respectively, in HepG2 cells.
Liao W; Chang BH; Mancini M; Chan L
J Cell Biochem; 2003 Aug; 89(5):1019-29. PubMed ID: 12874835
[TBL] [Abstract][Full Text] [Related]
12. Selective re-routing of prion protein to proteasomes and alteration of its vesicular secretion prevent PrP(Sc) formation.
Filesi I; Cardinale A; Mattei S; Biocca S
J Neurochem; 2007 Jun; 101(6):1516-26. PubMed ID: 17542810
[TBL] [Abstract][Full Text] [Related]
13. Scrapie-like prion protein is translocated to the nuclei of infected cells independently of proteasome inhibition and interacts with chromatin.
Mangé A; Crozet C; Lehmann S; Béranger F
J Cell Sci; 2004 May; 117(Pt 11):2411-6. PubMed ID: 15126640
[TBL] [Abstract][Full Text] [Related]
14. The retention of prion protein in the endoplasmic reticulum prevents N2A cells from proteasome inhibition-induced cytotoxicity.
Fang S; Wang R; Liu H; Zhuang W; Wang Z; Zhang J; Pei L; Liu Y; Su Y
Biochem Biophys Res Commun; 2017 Sep; 491(2):500-507. PubMed ID: 28669732
[TBL] [Abstract][Full Text] [Related]
15. Misfolded BiP is degraded by a proteasome-independent endoplasmic-reticulum-associated degradation pathway.
Donoso G; Herzog V; Schmitz A
Biochem J; 2005 May; 387(Pt 3):897-903. PubMed ID: 15610068
[TBL] [Abstract][Full Text] [Related]
16. Identification and characterization of two novel mutations (Q421 K and R123P) in congenital factor XII deficiency.
Kanaji T; Kanaji S; Osaki K; Kuroiwa M; Sakaguchi M; Mihara K; Niho Y; Okamura T
Thromb Haemost; 2001 Dec; 86(6):1409-15. PubMed ID: 11776307
[TBL] [Abstract][Full Text] [Related]
17. Polycystin-2 is regulated by endoplasmic reticulum-associated degradation.
Liang G; Li Q; Tang Y; Kokame K; Kikuchi T; Wu G; Chen XZ
Hum Mol Genet; 2008 Apr; 17(8):1109-19. PubMed ID: 18178578
[TBL] [Abstract][Full Text] [Related]
18. Proteasome-dependent degradation of cytochromes P450 2E1 and 2B1 expressed in tetracycline-regulated HeLa cells.
Huan JY; Streicher JM; Bleyle LA; Koop DR
Toxicol Appl Pharmacol; 2004 Sep; 199(3):332-43. PubMed ID: 15364548
[TBL] [Abstract][Full Text] [Related]
19. Charged bipolar suramin derivatives induce aggregation of the prion protein at the cell surface and inhibit PrPSc replication.
Nunziante M; Kehler C; Maas E; Kassack MU; Groschup M; Schätzl HM
J Cell Sci; 2005 Nov; 118(Pt 21):4959-73. PubMed ID: 16219680
[TBL] [Abstract][Full Text] [Related]
20. Degradation of connexin43 gap junctions involves both the proteasome and the lysosome.
Laing JG; Tadros PN; Westphale EM; Beyer EC
Exp Cell Res; 1997 Nov; 236(2):482-92. PubMed ID: 9367633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
